课题基金 / 基金详情

Tissue Culture Models of Lesch-Nyhan Disease

Tissue Culture Models of Lesch-Nyhan Disease
Lesch-Nyhan 病的组织培养模型
批准号:
7156557
负责人:
THOMAS L SHIRLEY
金额:
$5.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-16 至 2008-07-15

项目摘要

项目成果

THOMAS L SHIRLEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Although the underlying gene defect in Lesch-Nyhan Disease (LND) is known and altered basal ganglia function strongly implicated in the manifestation of neurological and behavioral abnormalities, the mechanistic connection between the lack of hypoxanthine-guanine phosphoribosyltransferase (HPRT) activity and selective dopamine loss remains unclear. Cell models of HPRT-deficiency provide a powerful and efficient approach to understanding the important molecular perturbations and rapid evaluation of potential therapeutic agents. As observed in vivo, selection for HPRT mutations in rodent dopaminergic cell lines has resulted in a consistent decrease in cellular dopamine content. This has not been reversible by subsequent restoration of HPRT function. We propose to utilize existing cell models as well as recent advancements in stem cell technology that generate dopaminergic neurons in vitro to investigate alterations in dopaminergic specification and differentiation conferred by HPRT deficiency. Understanding the link between purine salvage and dopamine homeostasis is key to unraveling the pathological basis of LND, while identifying the temporal window wherein HPRT is required for normal dopaminergic tone provides a meaningful basis for the development of effective therapeutics, especially gene replacement strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tissue Culture Models of Lesch-Nyhan Disease
  • 批准号:
    7268960
  • 项目类别:
  • 资助金额:
    $5.2万
  • 财政年份:
    2006
  • 负责人:
    THOMAS L SHIRLEY
  • 依托单位:
国内基金
海外基金
靶向Human ZAG蛋白的降糖小分子化合物筛选以及疗效观察
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    胡文静
  • 依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
  • 批准号:
    82370885
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨
  • 依托单位:
自闭症相关基因CHD8在非人灵长类大脑发育中的作用
HBV S-Human ESPL1融合基因在慢性乙型肝炎发病进程中的分子机制研究
  • 批准号:
    81960115
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    34.0万元
  • 批准年份:
    2019
  • 负责人:
    江建宁
  • 依托单位: